ICRA assigns AAA, A1+ ratings to Sun Pharma’s bank facilities

19 Aug 2015 Evaluate

Credit rating agency, ICRA has assigned the long-term/short-term rating of AAA/A1+ to the Rs 2000 crore Long-term/Short-term borrowing program of Sun Pharmaceutical Industries. The rating agency has also assigned the short-term rating of A1+ of the enhanced short-term bank facilities, from Rs 600 crore to Rs 2,000 crore to the company. In addition to this, the Rs 2000 crore Commercial Paper programme has been revalidated at A1+ by ICRA.

The assigned rating takes into consideration Sun Pharma’s strong business profile characterised by its leading market position and well established presence in the Indian Pharmaceutical market, its strong presence in U.S. generics segment (along with increasing focus on specialty segments) and financial profile characterised by strong credit metrics and sizeable cash reserves and liquidity.

Sun Pharma is a leading Indian pharmaceutical company engaged in developing, manufacturing and marketing formulations and APIs. Its business is broadly categorized in four segments - India Branded Generics, US Formulations, International Generics or RoW business and APIs.

Sun Pharma Inds. Share Price

1673.55 4.35 (0.26%)
19-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1673.55
Dr. Reddys Lab 1166.45
Cipla 1391.20
Zydus Lifesciences 881.10
Lupin 2178.20
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×